GlaxoSmithKline will close its facility in Carlisle, Pa., and cut 260 jobs, PennLive reported.
The U.K.-based drugmaker told PennLive the decision to close the facility was made to "consolidate volumes and generate efficiencies by moving the site’s production to our Guayama, Puerto Rico facility."
The facility, which was used to make GlaxoSmithKline's product Emergen-C, a vitamin C supplement, will be closed by the end of 2021.
Read the full article here.